Skip to main content

Table 3 GI; PI; aMMP8 levels (ng/ml) – Comparison between upper and lower jaw

From: Clinical parameters and inflammatory biomarkers among patients with multibracket appliances: a prospective clinical trial

Time Point

GI / PI / aMMp8

UPJ 

MV (SD)

LOJ 

MV (SD)

UPJ vs LOJ 

MV (SD)

p-value

Baseline (T0)

GI

0.36 (0.59)

0.32 (0.36)

0.04 (0.58)

0.5895

(N = 55)

PI

2.02 (0.77)

2.05 (0.71)

-0.03 (0.55)

0.6981

 

aMMP-8

3.03 (4.18)

2.90 (3.42)

0.13 (2.84)

0.7409

Time 1 (T1)

GI

0.35 (0.58)

0.30 (0.38)

0.05 (0.58)

0.4949

(N = 53)

PI

2.23 (1.00)

2.34 (0.94)

-0.11 (0.58)

0.1905

 

aMMP-8

5.37 (5.72)

4.85 (5.09)

0.52 (4.28)

0.3814

Time 2 (T2)

GI

0.50 (0.67)

0.45 (0.47)

0.05 (0.65)

0.5642

(N = 55)

PI

2.33 (0.95)

2.43 (0.95)

-0.10 (0.74)

0.3264

 

aMMP-8

4.33 (5.21)

4.23 (5.06)

0.10 (3.76)

0.8445

Time 3 (T3)

GI

0.67 (0.72)

0.69 (0.55)

-0.02 (0.69)

0.8216

(N = 55)

PI

2.38 (0.93)

2.57 (0.91)

-0.19 (0.83)

0.1022

 

aMMP-8

6.35 (7.19)

5.91 (6.81)

0.45 (5.67)

0.5623

Time 4 (T4)

GI

0.68 (0.70)

0.77 (0.65)

-0.10 (0.82)

0.3930

(N = 54)

PI

2.19 (0.97)

2.28 (0.79)

-0.09 (0.75)

0.3897

 

aMMP-8

5.32 (6.14)

5.11 (6.94)

0.21 (5.89)

0.7916

Time 5 (T5)

GI

0.86 (0.68)

1.05 (0.75)

-0.19 (0.78)

0.0869

(N = 50)

PI

2.29 (0.92)

2.47 (0.88)

-0.19 (0.70)

0.0631

 

aMMP-8

6.32 (6.10)

6.73 (6.58)

-0.41 (4.32)

0.5048

  1. SD Standard deviation, MV mean value, T0 Baseline 1 week before MBA, T1 3 weeks after MBA, T2 6 weeks after MBA, T3 3 months after MBA, T4 6 months after MBA, T5 1 year after MBA